BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33983905)

  • 1. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.
    DeSalvo J; Ban Y; Li L; Sun X; Jiang Z; Kerr DA; Khanlari M; Boulina M; Capecchi MR; Partanen JM; Chen L; Kondo T; Ornitz DM; Trent JC; Eid JE
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma.
    McBride MJ; Pulice JL; Beird HC; Ingram DR; D'Avino AR; Shern JF; Charville GW; Hornick JL; Nakayama RT; Garcia-Rivera EM; Araujo DM; Wang WL; Tsai JW; Yeagley M; Wagner AJ; Futreal PA; Khan J; Lazar AJ; Kadoch C
    Cancer Cell; 2018 Jun; 33(6):1128-1141.e7. PubMed ID: 29861296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes.
    El Beaino M; Rassy E; Hadid B; Araujo DM; Pavlidis N; Lin PP
    Curr Oncol Rep; 2020 Oct; 22(12):124. PubMed ID: 33025259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS-related transcription factors ETV4 and ETV5 are involved in proliferation and induction of differentiation-associated genes in embryonic stem (ES) cells.
    Akagi T; Kuure S; Uranishi K; Koide H; Costantini F; Yokota T
    J Biol Chem; 2015 Sep; 290(37):22460-73. PubMed ID: 26224636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRC signaling is crucial in the growth of synovial sarcoma cells.
    Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.
    Boulay G; Cironi L; Garcia SP; Rengarajan S; Xing YH; Lee L; Awad ME; Naigles B; Iyer S; Broye LC; Keskin T; Cauderay A; Fusco C; Letovanec I; Chebib I; Nielsen PG; Tercier S; Cherix S; Nguyen-Ngoc T; Cote G; Choy E; Provero P; Suvà ML; Rivera MN; Stamenkovic I; Riggi N
    Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
    de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
    Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.
    Tamaki S; Fukuta M; Sekiguchi K; Jin Y; Nagata S; Hayakawa K; Hineno S; Okamoto T; Watanabe M; Woltjen K; Ikeya M; Kato T; Toguchida J
    PLoS One; 2015; 10(11):e0142991. PubMed ID: 26571495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factors Etv4 and Etv5 mediate formation of the ureteric bud tip domain during kidney development.
    Kuure S; Chi X; Lu B; Costantini F
    Development; 2010 Jun; 137(12):1975-9. PubMed ID: 20463033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis.
    Lu BC; Cebrian C; Chi X; Kuure S; Kuo R; Bates CM; Arber S; Hassell J; MacNeil L; Hoshi M; Jain S; Asai N; Takahashi M; Schmidt-Ott KM; Barasch J; D'Agati V; Costantini F
    Nat Genet; 2009 Dec; 41(12):1295-302. PubMed ID: 19898483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.
    Kadoch C; Crabtree GR
    Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
    Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
    Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
    Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etv5, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2.
    Eo J; Han K; M Murphy K; Song H; Lim HJ
    J Endocrinol; 2008 Aug; 198(2):281-90. PubMed ID: 18492810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
    Nielsen TO; Poulin NM; Ladanyi M
    Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
    Brien GL; Remillard D; Shi J; Hemming ML; Chabon J; Wynne K; Dillon ET; Cagney G; Van Mierlo G; Baltissen MP; Vermeulen M; Qi J; Fröhling S; Gray NS; Bradner JE; Vakoc CR; Armstrong SA
    Elife; 2018 Nov; 7():. PubMed ID: 30431433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas.
    Smith SC; Palanisamy N; Martin E; Almenara J; McHugh JB; Choi EK; Lucas DR; Betz BL; Thomas D; Patel RM
    Histopathology; 2017 Mar; 70(4):657-663. PubMed ID: 27790742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.